Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
View/Download PDF

Translate this page into:

Original Article
14 (
02
); 179-185
doi:
10.1055/s-0044-1789578

Pilot Testing and Vernacular Translation of EORTC Patient Satisfaction Questionnaire (PATSAT-C33 and OUT-PATSAT7) at a Tertiary Care Cancer Center in India

Department of Radiation Oncology, Tata Memorial Centre/Advanced Centre for Treatment, Research and Education in Cancer (TMH/ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India
Neuro-Oncology Disease Management Group, Tata Memorial Centre/Advanced Centre for Treatment, Research and Education in Cancer (TMH/ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India
Author image
Corresponding author: Tejpal Gupta, MD, DNB, Kharghar 410210, Navi Mumbai, Maharashtra, India. tejpalgupta@rediffmail.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Purpose

Pilot testing and translation of the English version of European Organization for Research and Treatment of Cancer (EORTC) patient satisfaction cancer core questionnaire (PATSAT-C33) and complementary outpatient module (OUT-PATSAT7) into two Indian vernacular languages (Hindi and Marathi).

Methods

Patients undergoing fractionated radiotherapy for cancer with basic proficiency in respective language were included in the study after written informed consent. The English version of EORTC PATSAT-C33 and OUT-PATSAT7 questionnaire was pilot tested in 20 patients. The questionnaire was then translated into two Indian vernacular languages (Hindi and Marathi) using EORTC translation methodology. This included forward-translation by two independent professional translators into target languages (Hindi and Marathi) to create an intermediate version; back-translation into English by another independent pair of linguistic experts; and harmonization by comparing back-translated versions (English) to the original English version for reconciliation. The EORTC translation group provided suggestions and proofread the reconciliated versions (Hindi and Marathi) which were then administered to 20 patients in each language. Semistructured interviews were conducted for patients to identify problems in understanding the translation versions to make appropriate corrections/modifications to the questionnaire.

Results

Pilot testing of English version of PATSAT-C33 and OUT-PATSAT7 did not pose any major difficulty leading to subsequent translation into both target languages (Hindi and Marathi). Reconciliated version of the translated questionnaires was arrived at after incorporating suggestions and proofreading by the EORTC translation group. Pilot testing of the reconciliated questionnaires (Hindi and Marathi) did not identify major problems in understanding, difficult/confusing words, or upsetting questions leading to the adoption of the reconciliated version as final translated questionnaire without further modifications.

Conclusion

The English version of PATSAT-C33 and OUT-PATSAT7 has been successfully translated into Hindi and Marathi languages using standardized EORTC methodology. Psychometric properties of the same are currently being tested for validation in a larger Indian cohort.

Keywords

PubMed

Introduction

Patient satisfaction has been increasingly recognized as an effective yardstick for assessing quality of health care systems.1 Patient-reported experience measures (PREMs) have garnered significant attention in recent years due to growing emphasis on patient-centric approaches.12 Various PREMs have been designed to assess satisfaction in patients under oncologic care. The OUTPATSAT-35 is one such validated questionnaire (adapted from INPATSAT-32 for inpatients) for patients undergoing ambulatory oncologic treatment3 such as radiotherapy (RT) or chemotherapy (CT), which was recently translated4 and validated5 in two Indian vernacular languages (Hindi and Marathi) in a low-middle income country (LMIC) setting. Given remarkably similar domains and significantly overlapping items between INPATSAT-32 and OUTPATSAT-35 (RT and CT), the European Organization for Research and Treatment of Cancer (EORTC) has now developed a 33-item satisfaction with cancer care core questionnaire (PATSAT-C33) and a 7-item complementary module (OUT-PATSAT7) specific for outpatient care setting6 and have subsequently been applied in patients from 11 countries (in 10 languages).7 The EORTC PATSAT-C33 and OUT-PATSAT7 questionnaires are currently undergoing phase IV cross-cultural validation and psychometric assessment in various geo-ethnic populations across the globe.

Aim

This study was aimed at pilot testing and translation of the English version of EORTC PATSAT-C33 and OUT-PATSAT7 into two Indian vernacular languages (Hindi and Marathi).

Material and Methods

Eligibility

Adult patients (18 years and above) undergoing fractionated RT (≥ 10 fractions) on ambulatory basis in the definitive, adjuvant, or palliative setting for a pathologically proven diagnosis of cancer with a working knowledge of English, Hindi, or Marathi were included in the study after written informed consent. Patients who were unable to read or understand the questionnaire (illiterate or cognitively impaired) were excluded. The study was conducted at a large tertiary care cancer center in Western India and was duly approved by the Institutional Ethics Committee that functions in accordance with the Declaration of Helsinki. The study received competitive intramural research funding provided by the institute which had no role in the study design, conduct, analysis, or reporting of results. The study is registered with the Clinical Trials Registry of India (CTRI/2020/12/029685).

Questionnaires

The EORTC PATSAT-C33 (Supplementary File S1, available in online version) is a core questionnaire comprising of 33 close-ended questions, divided into four sections to evaluate the concerned health workers—doctors; RT technicians (for outpatient care) or nurses (for inpatient care); services and care organization; and overall. A five-point Likert scale with the following categories—(1) “poor”; (2) “fair”; (3) “good”; (4) “very good”; and (5) “excellent” is used for documenting response to individual items in the questionnaire, with a higher score indicating greater satisfaction with care and vice versa. The specialized outpatient module, OUT-PATSAT7 (online Supplementary File S1), deals with specific facets of ambulatory cancer care (daycare surgery, CT, and outpatient RT). In addition to the above, patients were also simultaneously administered the EORTC multidimensional quality-of-life (QOL) core questionnaire (QLQ-C30) in the same language as PATSAT-C33 and OUT-PATSAT7.

Methodology

The study methodology is briefly described and summarized in Fig. 1. The index English version of the questionnaires (PATSAT-C33 and OUT-PATSAT7) was administered to 20 patients with basic proficiency in English within 3 days (± ) of completion of their planned RT regimen. After filling the questionnaires, an interview was conducted using a semistructured format to assess appropriateness of the items in the questionnaire in the tested population, which was documented patient-wise and then reorganized under the same structured format but for each item (item-wise). After pilot testing, translation of the questionnaire was done according to standardized and validated EORTC methodology for such translations (Fig. 1).8 Reconciliation was done by a third linguistic expert after merging information from both forward-translated versions. The intermediate version of either language was then back-translated and compared with the original questionnaire for harmonization. The intermediate versions were independently proofread by the EORTC translation group who provided suggestions for further minor modifications (modified intermediate version). This was subsequently administered to 20 patients each (basic proficiency in respective vernacular language) for pilot testing. As per standard methodology, all patients underwent semistructured interviews as mentioned above. Patient concerns were addressed and suggestions if any were incorporated to create the final translated version of the questionnaire in the respective vernacular language.

Flowchart describing standard European Organization for Research and Treatment of Cancer (EORTC) translation methodology.
Fig. 1: Flowchart describing standard European Organization for Research and Treatment of Cancer (EORTC) translation methodology.

Statistical Analysis

Data completeness was calculated for EORTC PATSAT-C33 and OUT-PATSAT7 as well as QLQ-C30 questionnaire items. QLQ-C30 item scores were converted to raw scores in accordance with the EORTC recommendations.9 All statistical analysis was done using Statistical Package for Social Sciences (SPSS) version 24.0.

Results

A total of 60 patients who filled these questionnaires (20 in each language—English, Hindi, and Marathi) constitute the present study cohort. Sociodemographic factors, clinical parameters, and treatment characteristics of included patients are briefly summarized in Table 1. None of the 20 patients included in pilot testing of the English version of PATSAT-C33 and OUT-PATSAT7 questionnaires reported any problems in understanding, difficult/confusing words, or upsetting questions during semistructured interviews. Translation of the questionnaires was done into the two Indian vernacular languages, Hindi and Marathi (Fig. 1), that are commonly spoken in Western India. The intermediate versions in both vernacular languages were proofread by the EORTC translation group and their suggestions incorporated in the modified intermediate versions which was used for pilot testing in 20 patients each with basic proficiency in Hindi and Marathi languages in conjunction with language-appropriate version of EORTC QLQ-C30. Some translated words (in Hindi and/or Marathi) in the PATSAT-C33 and OUT-PATSAT7 questionnaires were deemed difficult to understand by patients during semistructured interviews. These were related to vernacular translation of few specific words (privacy, attention, consultation, provision, and physiotherapist) which could not have been simplified further without losing their essence and meaning. None of the patients suggested further changes (corrections/modifications) to the content or wording, hence, the modified intermediate versions were adopted as the final translated questionnaires (online Supplementary Files S2 and S3, respectively) in both Hindi and Marathi languages, respectively.

Table 1
Characteristics of the study cohort (
N
 = 60)

Characteristics

Number (%) of patients

Age

 18–40 y

26 (43.3)

 41–60 y

26 (43.3)

 > 60 y

08 (13.4)

Gender

 Female

16 (26.7)

 Male

44 (73.3)

Cancer site

 Brain tumor

35 (58.3)

 Head-neck cancer

19 (31.7)

 Lung cancer

03 (05.0)

 Esophageal cancer

01 (01.7)

 Penile cancer

01 (01.7)

 Cervical cancer

01 (01.7)

Stage of disease

 Early disease/favorable prognosis

21 (35)

 Advanced disease/unfavorable prognosis

39 (65)

Karnofsky Performance Status (KPS)

 KPS = 70

05 (08.4)

 KPS = 80

32 (53.3)

 KPS = 90

23 (38.3)

Educational qualification

 Primary/middle school

10 (16.7)

 Secondary/higher secondary school

28 (46.7)

 Graduation

18 (30.0)

 Postgraduation

04 (06.6)

Occupation

 Student/unoccupied/retired

21 (35.0)

 Farming

01 (01.7)

 Business

04 (06.6)

 Salaried work

34 (56.7)

Working status (n = 39)

 Working during RT

09 (20.5)

 Break from work during RT

30 (79.55)

Economic status (World Bank fiscal year 2018)

 Low-income group

19 (31.7)

 Lower middle-income group

22 (36.7)

 Upper middle-income group

11 (18.3)

 High-income group

03 (05.0)

 Not available/not known

05 (08.3)

Abbreviation: RT, radiotherapy.

All patients (N = 60) responded to all the items of EORTC PATSAT-C33 and OUT-PATSAT7 as well as QLQ-C30 questionnaires resulting in full compliance with zero data attrition. Summary satisfaction scores in terms of mean scores with standard deviation (SD) and median scores (range) for various scales of all tested domains in PATSAT-C33 and OUT-PATSAT7 are reported in Table 2. Satisfaction scores were generally high for all scales with highest mean scores (4.1) obtained for Q32 (environment) and Q33 (general satisfaction) while lowest mean score (2.9) seen for waiting time for medical appointment (Q36). The mean (± SD) and median (range) scores of all individual questions of QLQ-C30 for the entire study cohort (N = 60) are summarized in Table 3. Higher scores for functional and global health status scales reflect healthy level of living, while lower scores for symptom scale reflects better symptom control. There were no significant correlations between QLQ-C30 domains and PATSAT-C33/OUT-PATSAT7 scales indicating that they assess different aspects of patient-reported measures. While QLQ-C30 measures specific aspects of cancer symptoms and treatment outcomes from the patient's perspective (patient-reported outcome measures), PATSAT questionnaires measure patient's view of health service experiences (PREM) allowing direct feedback to health care administrators (planners and policy makers) to improve health care system.

Table 2
Mean with standard deviation (SD) and median (range) scores of individual questions in EORTC PATSAT-C-33 and OUTPATSAT7 in all three languages combined (
N
 = 60)

No:

Question

Mean (SD)

Median (range)

PATSAT-C33

Doctors

1

Their awareness of the care and treatment you received previously?

3.95 (1.0)

4 (2–5)

2

The attention they gave to your physical symptoms?

3.9 (0.9)

4 (2–5)

3

Their thoroughness in treating your physical symptoms?

3.9 (0.9)

4 (1–5)

4

The information they gave you about your illness?

3.9 (1.0)

4 (1–5)

5

The information they gave you about your medical tests and treatment?

4.0 (1.0)

4 (1–5)

6

The attention they gave to your opinion about the choice of your treatment (in case of possible choices)?

3.6 (1.0)

4 (1–5)

7

The interest they showed in you as a person?

3.9 (1.0)

4 (1–5)

8

The comfort and support they gave you?

4.0 (1.1)

4 (1–5)

9

The frequency of their visits/consultations?

3.8 (1.0)

4 (2–5)

10

The time they devoted to you?

3.9 (1.0)

4 (2–5)

Nurses or radiotherapy technicians

11

The attention they gave to your physical comfort?

3.8 (0.9)

4 (2–5)

12

The information they gave you about your care and treatment?

3.9 (1.1)

4 (1–5)

13

The advice they gave you on managing your physical symptoms?

3.8 (1.0)

4 (1–5)

14

The interest they showed in you as a person?

3.8 (1.0)

4 (1–5)

15

The comfort and support they gave you?

3.8 (1.0)

4 (1–5)

16

Their promptness in answering your specific requests?

3.7 (1.0)

4 (1–5)

17

The time they devoted to you?

3.8 (1.0)

4 (1–5)

Services and care organization

18

The ease of recognizing the roles and responsibilities of the different caregivers (doctors, nurses, physiotherapists, psychologists, etc.) involved in your care?

3.8 (0.9)

4 (2–5)

19

The exchange of information between the different caregivers (doctors, nurses, physiotherapists, psychologists, etc.)?

3.7 (0.9)

4 (2–5)

20

The way doctors, nurses, and other caregivers involved in your care seem to work together as a team?

3.9 (0.9)

4 (2–5)

21

The exchange of information with other care services in the community (general practitioner, home care, nursing house, social services, etc.)?

3.4 (0.9)

4 (1–5)

22

The kindness and helpfulness of the technical, reception, laboratory personnel, etc.?

3.8 (1.0)

4 (2–5)

23

The information provided on the scheduling of medical tests, treatment, or care?

3.8 (0.9)

4 (2–5)

24

The information provided on the overall supportive services available (social, psychological, physiotherapy, dietitian services, support group, etc.)?

3.6 (1.1)

4 (1–5)

25

The information provided by doctors, nurses, and other caregivers on things you could do to improve your health or prevent illness?

3.9 (0.9)

4 (2–5)

26

The waiting time for obtaining results of medical tests?

3.1 (1.0)

3 (1–5)

27

The waiting time for undergoing medical tests and/or treatments?

3.1 (1.0)

3 (1–5)

28

The privacy given when you were examined or treated?

3.7 (1.0)

4 (1–5)

29

The opportunity for your family or those close to you to be involved in your care (talking to doctors, receiving disease and care information, etc.)?

3.7 (1.0)

4 (1–5)

30

The ease of access (parking, means of transport, etc.)?

3.2 (1.2)

3 (1–5)

31

The ease of finding your way to the different departments in the hospital?

3.5 (1.1)

4 (1–5)

32

The environment of the building (cleanness, spaciousness, calmness, etc.)?

4.1 (1.0)

4 (2–5)

General

33

How would you rate the care you received in this hospital?

4.1 (1.0)

4 (2–5)

OUT-PATSAT7

34

The opportunity to see the same caregivers when you come to the outpatient clinic?

3.5 (1.0)

3.5 (2–5)

35

The ease of arranging medical appointments at convenient times?

3.5 (1.0)

4 (2–5)

36

The waiting time before obtaining a medical appointment?

2.9 (1.2)

3 (1–5)

37

The ease of communicating with the hospital services from home?

3.2 (1.2)

3 (1–5)

38

The information provided about what you should/should not do after you leave your hospital appointment?

3.7 (1.0)

4 (2–5)

39

The information on who to contact if you are worried after you leave your hospital appointment?

3.5 (1.1)

4 (1–5)

40

The provision of follow-up by the different caregivers (doctors, nurses, physiotherapists, psychologists, etc.) after treatment?

3.8 (1.0)

4 (2–5)

Abbreviation: EORTC, European Organization for Research and Treatment of Cancer.

Table 3
Mean with standard deviation (SD) and median (range) scores of different domains of EORTC QLQ-C30 questionnaire in all three languages combined (
N
= 60)

Domaina

Mean (SD)

Median (range)

Functional domain

 Physical functioning scale

76.3 (20.0)

80.0 (0–100)

 Role functioning scale

78.0 (23.1)

83.3 (0–100)

 Emotional functioning scale

68.9 (23.0)

66.7 (8.3–100)

 Cognitive functioning scale

74.7 (25.0)

83.3 (16.7–100)

 Social functioning scale

71.7 (28.0)

83.3 (0–100)

Symptom domain

 Fatigue scale

34.8 (24.4)

33.3 (0–100)

 Nausea and vomiting scale

30.0 (28.1)

16.7 (0–100)

 Pain scale

32.5 (26.2)

33.3 (0–100)

 Dyspnea scale

16.1 (23.3)

0 (0–100)

 Sleep scale

30.5 (35.9)

33.3 (0–100)

 Appetite loss scale

39.4 (31.5)

33.3 (0–1000

 Constipation scale

30.5 (29.6)

33.3 (0–100)

 Diarrhea scale

17.2 (28.4)

0 (0–100)

Financial domain

 Financial difficulties scale

31.7 (30.3)

33.3 (0–100)

Global health domain

 Global health status scale

62.5 (22.5)

58.3 (8.3–100)

Abbreviation: EORTC, European Organization for Research and Treatment of Cancer.

Higher scores of functional, financial, and global health statuses reflect better quality of life, while lower scores of symptom scales reflect better symptom control.

Discussion

Patient satisfaction, a key indicator of health care quality, requires comprehensive yet dedicated tools to assess patient experience through various phases of care across diverse health care settings. Although several PREMs have been designed, developed, and described in the indexed medical literature, only a few pertain to oncologic care and even fewer have been translated and validated in Indian vernacular languages.451011121314 One such questionnaire (OUTPATSAT-35RT) that assesses patient satisfaction on ambulatory RT was recently translated and validated in two Indian vernacular languages.45 However, given that cancer care spans across different settings including inpatient care and outpatient services, it was deemed necessary to revise the existing questionnaires to comprehensively assess patients' perceived quality of care across cancer care settings to create an overarching cancer care questionnaire. Brédart et al reported the initial steps taken to produce a satisfaction with cancer care core questionnaire (applicable for inpatient and outpatient settings) and a complementary cancer outpatient satisfaction with care module, which later resulted in the EORTC PATSAT-C33 and OUT-PATSAT7 questionnaires, respectively.6 The latter module was intended to cover outpatient satisfaction with daycare surgery, ambulatory RT, outpatient CT, and home-based cancer therapy. A preliminary list of cancer issues to complement IN-PATSAT32 and specifically address outpatient setting was prepared after reviewing multiple questionnaires in literature.31516 After several rounds of revision to eliminate redundancy, ensure clarity, and define cancer care issues with approximately the same level of abstraction and specificity, a consolidated list of 88 issues was presented to patients and health care providers for rating the appropriateness of items using semistructured interviews. Items were deleted depending on reported low relevance and low priority. The remaining 57 items were then operationalized as questionnaire items into preliminary questionnaires (cancer core and outpatient modules). In the next developmental phase, the preliminary satisfaction questionnaires were translated into 10 languages and pretested in 11 countries in order to identify/solve potential problems in its administration and to identify redundant or missing issues.7 This led to the retention of 40 items which was operationalized into EORTC PATSAT-C33 and OUT-PATSAT7 questionnaires after testing of scale properties. A large-scale phase IV cross-cultural validation study is now underway globally to establish psychometric properties of the questionnaire during which these questionnaires are being administered to four main groups of patients based on the cancer care settings at three assessment times. Cross-cultural applicability and acceptability, reliability, validity, responsiveness to change, and cross-cultural invariance of psychometric properties of these questionnaires will be assessed and reported in due course.

Compared to other satisfaction tools, PATSAT-C33 and OUT-PATSAT7 questionnaires are considered to be much more inclusive and comprehensive in context with care settings.6 The present study pilot tested and translated the English version of EORTC PATSAT-C33 and OUT-PATSAT7 into two Indian vernacular languages (Hindi and Marathi), which are commonly spoken in Western India. There was a general trend of high satisfaction scores which can be somewhat misleading due to relatively small sample size and potential bias based on patient's perception of likely negative impact on further treatment in case of reporting low levels of satisfaction. Lowest satisfaction scores pertained to questions concerning waiting times—for appointments (mean score 2.9) and for daily treatments (mean score 3.1). This is understandable as the study was conducted in a busy RT department with high footfalls that poses major challenges in providing early appointments and efficient scheduling of visits during RT on a daily basis.

Limitations

Although the outpatient module (OUT-PATSAT7) is applicable to different outpatient settings, this study was restricted to patients undergoing ambulatory RT only limiting generalizability. The present cohort comprised mainly of patients with brain tumors and head-neck cancers with minimal representation of other commonly prevalent cancers (breast and cervix) in India. Only patients receiving fractionated RT (≥ 10 fractions) were eligible, excluding patients receiving hypofractionated regimens (typically 1–5 fractions) including stereotactic radiosurgery or stereotactic body RT limiting applicability in that subset. Finally, the questionnaire does not address some of the unique challenges faced by health care systems in resource-constrained LMIC settings.

Conclusion

This study successfully completed pilot testing and translation of EORTC PATSAT-C33 and OUT-PATSAT7 questionnaires into two Indian vernacular languages (Hindi and Marathi) using standardized methodology. Psychometric properties of the questionnaire are presently being assessed for validation testing in a larger Indian cohort.

Supplementary Material

Supplementary Material

Supplementary Material

Supplementary Material

References

  1. Crossing the Quality Chasm: A New Health System for the 21st Century [Internet] Institute of Medicine (US) Committee on Quality of Health Care in America.
    [Google Scholar]
  2. , , , . A systematic review of evidence on the links between patient experience and clinical safety and effectiveness. BMJ Open. 2013;3(01):e001570.
    [Google Scholar]
  3. , , , et al , . An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32) Eur J Cancer. 2005;41(14):2120-2131.
    [Google Scholar]
  4. , , , , , , . Pilot testing and vernacular translation of a questionnaire for assessment of satisfaction in patients on radiotherapy in India. Indian J Cancer. 2021;58(04):573-582.
    [Google Scholar]
  5. , , , et al . Validation testing of OUTPATSAT-35RT questionnaire to assess satisfaction in patients on outpatient radiotherapy in a large Indian cohort. J Cancer Res Ther 2024
    [Google Scholar]
  6. , , , et al , . The European Organization for Research and Treatment of Cancer - satisfaction with cancer care questionnaire: revision and extended application development. Psychooncology. 2017;26(03):400-404.
    [Google Scholar]
  7. , , , et al , . Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT-PATSAT7) Eur J Cancer Care (Engl) 2018;27(01):
    [Google Scholar]
  8. , , , et al , . Translation procedures for standardised quality of life questionnaires: the European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer. 2007;43(12):1810-1820.
    [Google Scholar]
  9. , , , , , , . EORTC QLQ-C30 Scoring Manual. European Organisation for Research and Treatment of Cancer 2001. Accessed august 12, 2024 at:
    [Google Scholar]
  10. , , , , , , . A comprehensive assessment of satisfaction with care for cancer patients. Support Care Cancer. 1998;6(06):518-523.
    [Google Scholar]
  11. , , , , , , . Perception of quality in a radiation oncology department: is it different for patients and health care providers? Indian J Cancer. 2016;53(01):152-157.
    [Google Scholar]
  12. , , , et al , . Quality of care in the oncology outpatient setting from patients' perspective: a systematic review of questionnaires' content and psychometric performance. Psychooncology. 2015;24(04):382-394.
    [Google Scholar]
  13. , , , , , , . A survey of satisfaction with treatment among brain tumor patients. South Asian J Cancer. 2020;9(04):262.
    [Google Scholar]
  14. , , , et al . Measuring satisfaction in breast cancer patients receiving ambulatory care: a validation study. Indian J Med Paediatr Oncol. 2022;43(06):473-479.
    [Google Scholar]
  15. , , , , , , . Patient experiences of continuity of cancer care: development of a new medical care questionnaire (MCQ) for oncology outpatients. Value Health. 2009;12(08):1180-1186.
    [Google Scholar]
  16. , , , , , . Measuring cancer care coordination: development and validation of a questionnaire for patients. BMC Cancer. 2011;11:298.
    [Google Scholar]
Show Sections